WELCOME TO The PHARMACEUTICAL REPORT
Newsletter | Member Login | Signup
Home > Companies > Aptalis Pharmaceutical Technologies (now Adare Pharmaceuticals)
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
PharmaNewsIntelligence | March 11, 2020
Oregon Health & Science University (OHSU) held the first-ever gene therapy clinical trial, BRILLIANCE, to address blindness-causing gene mutation, LCA10, according to a recent press release The clinical trial, sponsored by Allergan plc and Editas Medicine, is one of 14 different clinical trials investigating new genetic treatments for ophthalmic conditions and nearly 50 vision-related clinical trials. The procedure uses gene-editing tool CRISPR to edit human genes, also known as in vivo gene...
Business Insights
Suvoda LLC | May 13, 2022
Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system, and rare disease, today announced they have entered into an agreement to partner with N-SIDE — a deeptech company that empowers organizations in the clinical trials industry to make better decisions and optimize the use of critical resources. To date, the two companies have successfully partnered on more than 100 clinical ...
European Pharmaceutical Manufacturer Magazine | February 17, 2020
The companies will combine their expertise across process automation and data analytics to aid pharmaceutical companies through a more efficient manufacturing process. Honeywell will utilise Bigfinite’s software-as-a-service (SaaS) to enhance manufacturing process operations by consolidating compliance-related manufacturing data into a single, visual interface for drug manufacturers. By combining data across laboratories, batch management, control, quality management and more, the companie...
Pharmacy Market
Theralink Technologies | April 20, 2022
Theralink Technologies a precision medicine company with a novel phosphoprotein-based assay for breast cancer, today announced that it has significantly expanded the adoption of its Laser Capture Microdissection and Reverse Phase Protein Array precision medicine technology to biopharmaceutical companies, including multinational healthcare corporations. The Company has supported 41 preclinical and clinical studies for 18 biopharma companies and is currently undergoing discussions to develop Compa...
PHARMACY MARKET
Article
Video
Pharma Tech
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE